FilingSEC EDGAR8-K
Medicus Pharma Completes 1-for-50 Reverse Stock Split
· SEC accepted
StageConsolidation Effective
Filing content
The company implemented a 1-for-50 reverse stock split effective October 12, 2026, and began trading on a post-consolidation basis on Nasdaq.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…